Net Cash Provided by (Used in) Operating Activities |
-94.3K |
USD |
+59.6% |
Q1 2022 |
Q1 2022 |
Net Cash Provided by (Used in) Financing Activities |
50K |
USD |
-74.1% |
Q1 2022 |
Q1 2022 |
Common Stock, Shares Authorized |
6.5B |
shares |
0% |
Q4 2022 |
FY 2022 |
Common Stock, Shares, Issued |
6.24B |
shares |
+6.32% |
Q4 2022 |
FY 2022 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2022 |
FY 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-79.5K |
USD |
-250% |
Q1 2022 |
Q1 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
10.4K |
USD |
-91.3% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Valuation Allowance |
1.93M |
USD |
+13.3% |
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Gross |
1.93M |
USD |
+13.3% |
Q4 2022 |
FY 2022 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-169K |
USD |
+94.8% |
Q3 2022 |
Q3 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
9.18M |
USD |
+13.3% |
Q4 2022 |
FY 2022 |
Additional Paid in Capital |
16.2M |
USD |
+5.38% |
Q4 2022 |
FY 2022 |
Depreciation, Depletion and Amortization |
3.62K |
USD |
0% |
Q1 2022 |
Q1 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2022 |
FY 2022 |
Interest Expense |
806K |
USD |
-34.9% |
Q4 2022 |
FY 2022 |